US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Size and Forecasts (2020 – 2030)

US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Size and Forecasts (2020 – 2030), Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, Consumables, Accessories, and Software), Application (Cancer Diagnosis, Genetic Disease Diagnosis, Infectious Disease Diagnostic, and Others), and End User (Diagnostic Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnological Companies, and Others)

Send Enquiry
Item ID: TIPRE00030087 Category: Tags: , ,

$2,100$3,500

Description

The US fluorescence in-situ hybridization (FISH) imaging systems market is expected to reach US$ 0.733 billion in 2030 from US$ 0.419 billion in 2022. The market is estimated to grow with a CAGR of 7.3% from 2022 to 2030.

The key factors driving the market’s growth are rising prevalence of target disorders and the increasing R&D investments in in-vitro diagnostics. However, high cost of fish imaging systems and procedures is hampering the market’s growth to a certain extent.

Market Opportunities of Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market

FISH imaging systems are witnessing a remarkable evolution due to the surge in technological advancements, which result in cutting-edge innovations transforming the landscape of genetic research and diagnostics. These advancements include enhanced optics, more sensitive and versatile fluorophores, and sophisticated automation features. Modern FISH imaging systems, integrated with these upgraded features, offer greater sensitivity, improved image resolution, and faster processing times. Moreover, these technological advancements have extended the application scope of FISH imaging from cancer diagnosis to genetic predisposition testing. In July 2021, BioView and Capio Biosciences collaborated to create a platform for collecting circulating tumor cells (CTCs) from whole blood. By integrating their technologies, these companies further worked on improving the CTC liquid biopsy downstream analysis. Similarly, in collaboration, BioView and Capio Biosciences partnered with RUBYnanomed in December 2020 to create a unique imaging solution to accelerate the acceptance and adoption of CTC technology in clinics to enhance cancer detection. Thus, technological advancements in FISH imaging systems create significant opportunities for companies in the fluorescence in-situ hybridization (FISH) imaging systems market.

Factors Hampering Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market

Computerized tomography (CT) scan, immunohistochemistry (IHC), bone scan, FISH imaging, magnetic resonance imaging (MRI), positron emission tomography (PET) scan, ultrasound, and X-ray are among the tests used to detect cancer. FISH imaging analysis is a less commonly used method in cancer detection because of its relatively higher cost than other methods. In addition to the equipment cost, the expenses associated with reagents, other consumables, and specialized personnel appointments can add to the overall cost of evaluation based on FISH imaging. For instance, the detection of ALK gene non-small cell lung cancer by IHC costs US$ 90.07 in the US for every test, which is less than either independent or parallel testing by FISH and IHC (costing ~US$ 441.85 in the US). Thus, the high cost of procedures and systems limits the growth of the fluorescence in situ hybridization (FISH) imaging systems market.

Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market: Segmental Overview

Based on product, the fluorescence in-situ hybridization (FISH) imaging systems market is segmented into instruments, consumables, accessories, and software. The consumables segment held a larger market share in 2022 and is anticipated to register a higher CAGR. Consumables are the most promising segment of the fluorescence in-situ hybridization (FISH) imaging system market that will contribute to tremendous growth in the coming years. FISH consumables include hybridization buffers, probes, tag detection kits, signal amplification detection kits, and others. The presence of manufacturers such as Abbott, F. Abnova, and Thermo Fisher Scientific bolsters the market for the consumables segment. Additionally, these products are frequently used in various research diagnosis processes, which is expected to propel consumption. Thus, the presence of various market players offering probes & kits and technological advancements by market players are likely to propel the market for the segment in the coming years.

Based on application, the fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnosis, and others. The cancer diagnosis segment held a larger market share in 2022 and is anticipated to register a higher CAGR. FISH technology has tremendously benefited cancer diagnosis. FISH imaging systems can look for gene changes and help detect anomalies. According to Cancer Research UK, FISH testing is used for the diagnosis of several cancers, including breast cancer, lymphoma, lung cancer, prostate cancer, chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), myeloma, Ewings sarcoma, and melanoma skin cancer.

Based on end user, the fluorescence in-situ hybridization (FISH) imaging systems market is segmented into diagnostic laboratories, contract research organization, pharmaceutical and biotechnological companies, and others. The diagnostic laboratories segment held a larger market share in 2022 and same segment is anticipated to register a higher CAGR. The diagnostic laboratories are involved in various research projects to develop several technologies and products for fluorescence in-situ hybridization (FISH) imaging processes. Unprecedented developments in research and technologies have created the potential for transformation in the healthcare and life sciences sectors. The clinical applications of fluorescence in-situ hybridization (FISH) imaging systems are vast and offer opportunities to enhance diagnosis and treatment capabilities for chronic disease. They offer huge potential in gene discovery and diagnosis of rare genetic disorders. The technologies are increasingly used to analyze rare and common genetic factors influencing the development of common diseases, such as cancer, high blood pressure, diabetes, and renal diseases.

Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market: Geographical Overview

The growing demand for advanced diagnostic tools in molecular genetics and cytogenetics and the rising prevalence of genetic disorders and cancer fuel the adoption of fluorescence in-situ hybridization (FISH) imaging systems. As per data published by the American Cancer Society in 2022, there are around 1.9 million new cancer cases diagnosed in the US and 609,360 cancer deaths. These systems offer high-resolution imaging of genetic material, enabling researchers and clinicians to detect chromosomal abnormalities and gene mutations with greater accuracy. Furthermore, the increasing focus on personalized medicine and targeted therapies has led to an upsurge in research activities involving genetic analysis, bolstering the demand for FISH imaging systems. The ability of these systems to provide detailed spatial information on gene sequences directly within cells has proven invaluable in both research and clinical applications. The popularity of technological advancements in FISH imaging systems, such as improved automation, higher throughput, and enhanced image analysis software, has also increased in recent years. As a result, laboratories and medical institutions are better equipped to handle larger volumes of samples and generate precise results efficiently. Thus, the abovementioned factors will fuel the fluorescence in-situ hybridization (FISH) imaging systems market growth in the US.

A few of the major primary and secondary sources referred to while preparing the report on the fluorescence in-situ hybridization (FISH) imaging systems market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

Cancer Diagnosis Segment by Application to Account Larger Share in Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market during 2022–2030

According to our latest study on “US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Size and Forecasts (2020 – 2030), Country Share, Trends, and Growth Opportunity Analysis” the market is expected to grow from US$ 0.419 billion in 2022 and is expected to reach US$ 0.733 billion by 2030; it is anticipated to record a CAGR of 7.2% from 2022 to 2030. The report highlights the key factors driving the growth of fluorescence in-situ hybridization (FISH) imaging systems and prominent players with their developments in the market.

Fluorescence in situ hybridization (FISH) is a molecular technique for cytogenetic analysis. This technique uses fluorescent probes that bind to only particular parts of a nucleic acid sequence with a high degree of sequence complementarity. FISH detects the presence or absence of specific DNA sequences on chromosomes. FISH is often used to find specific features in DNA/RNA targets for medicine, genetic counseling, and species identification.

The fluorescence in-situ hybridization (FISH) imaging systems market, by product, is segmented into instruments, consumables, accessories, and software. The consumables segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR. Based on application, the fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnosis, and others. The cancer diagnosis segment held a larger market share in 2022. FISH technology has tremendously benefited cancer diagnosis. FISH imaging systems can look for gene changes and help detect anomalies. According to Cancer Research UK, FISH testing is used for the diagnosis of several cancers, including breast cancer, lymphoma, lung cancer, prostate cancer, chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), myeloma, Ewings sarcoma, and melanoma skin cancer. Based on end user, the fluorescence in-situ hybridization (FISH) imaging systems market is segmented into diagnostic laboratories, contract research organization, pharmaceutical and biotechnological companies, and others. The diagnostic laboratories segment held a larger market share in 2022 and same segment is anticipated to register a higher CAGR.

Euroclone SpA, TissueGnostics GmbH, Agilent Technologies Inc, Abnova Taiwan Corp, BioGenex Laboratories Inc, Leica Biosystems Nussloch GmbH, MetaSystems Probes GmbH, Bio-View Ltd, Thermo Fisher Scientific Inc, Applied Spectral Imaging, and PerkinElmer Inc are among the leading companies operating in the global Fluorescence In-Situ Hybridization (FISH) Imaging Systems market.

Companies operating in the fluorescence in-situ hybridization (FISH) imaging systems market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the fluorescence in-situ hybridization (FISH) imaging systems market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall fluorescence in-situ hybridization (FISH) imaging systems market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

A few of the significant developments by key market players are listed below.

• In May 2023, Pfizer and Thermo Fisher Scientific Inc entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in over 30 countries across Latin America, Africa, the Middle East, and Asia where advanced genomic testing was previously limited or unavailable. Access to local NGS testing can help enable faster analysis of related genes, allowing healthcare providers to choose the best medicine for that specific patient.

• In April 2023, Agilent Technologies Inc had signed a memorandum of understanding with Theragen Bio in South Korea. As part of the partnership agreement, Agilent and Theragen Bio combined their respective strengths in cancer genomic profiling design, engineering knowledge and software expertise to drive localized analysis capabilities and accelerate treatment decisions.

• In December 2021, BioGenex Laboratories Inc had launched three new primary immunohistochemistry (IHC) antibodies for cancer diagnostics, which includes CD8A, CD56, and CD163.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Hybrid Composites Market, by Fiber Type
1.3.2 Europe Hybrid Composites Market, by Resin
1.3.3 Europe Hybrid Composites Market, by Application
1.3.4 Europe Hybrid Composites Market, by Country
2. Key Takeaways
3. Research Methodology
3.1 Scope of the Study
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis formulation:
3.2.4 Macro-economic factor analysis:
3.2.5 Developing base number:
3.2.6 Data Triangulation:
3.2.7 Country level data:
4. Europe Hybrid Composites Market Landscape
4.1 Market Overview
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants:
4.2.2 Bargaining Power of Buyers:
4.2.3 Bargaining Power of Suppliers:
4.2.4 Competitive Rivalry:
4.2.5 Threat of Substitutes:
4.3 Ecosystem Analysis
4.4 Expert Opinions
5. Europe Hybrid Composites Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Demand for Lightweight Materials in Aerospace & Defense Industry
5.1.2 Rising Use of Hybrid Composites in Wind Energy and Automotive Industries
5.2 Market Restraints
5.2.1 High Cost and Recyclability Issues of Hybrid Composites
5.3 Market Opportunities
5.3.1 Increasing Demand for Nanocomposites
5.4 Future Trends
5.4.1 Rise in Adoption of Biocomposites
5.5 Impact Analysis
6. Hybrid Composites – Europe Market Analysis
6.1 Europe Hybrid Composites Market Overview
6.2 Europe Hybrid Composites Market –Volume and Forecast to 2028 (Kilo Tons)
6.3 Europe Hybrid Composites Market –Revenue and Forecast to 2028 (US$ Million)
7. Europe Hybrid Composites Market Analysis – By Fiber Type
7.1 Overview
7.2 Europe Hybrid Composites Market, By Fiber Type (2022 and 2028)
7.3 Carbon/Aramid
7.3.1 Overview
7.3.2 Carbon/Aramid: Europe Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Carbon/Aramid: Europe Hybrid Composites Market – Volume and Forecast to 2028 (Kilo Tons)
7.4 Carbon/Glass
7.4.1 Overview
7.4.2 Carbon/Glass: Europe Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Carbon/Glass: Europe Hybrid Composites Market – Volume and Forecast to 2028 (Kilo Tons)
7.5 High-Modulus Polypropylene (HMPP)/Carbon
7.5.1 Overview
7.5.2 High-Modulus Polypropylene (HMPP)/Carbon: Europe Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 High-Modulus Polypropylene (HMPP)/Carbon: Europe Hybrid Composites Market – Volume and Forecast to 2028 (Kilo Tons)
7.6 Ultra High Molecular Weight Polyethylene (UHMWPE)/ Carbon
7.6.1 Overview
7.6.2 Ultra High Molecular Weight Polyethylene (UHMWPE)/ Carbon: Europe Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 Ultra High Molecular Weight Polyethylene (UHMWPE)/ Carbon: Europe Hybrid Composites Market – Volume and Forecast to 2028 (Kilo Tons)
7.7 Others
7.7.1 Overview
7.7.2 Others: Europe Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
7.7.3 Others: Europe Hybrid Composites Market – Volume and Forecast to 2028 (Kilo Tons)
8. Europe Hybrid Composites Market Analysis – By Resin
8.1 Overview
8.2 Europe Hybrid Composites Market, By Resin(2022 and 2028)
8.3 Thermoset
8.3.1 Overview
8.3.2 Thermoset: Europe Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Thermoplastic
8.4.1 Overview
8.4.2 Thermoplastic: Europe Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Hybrid Composites Market Analysis – By Application
9.1 Overview
9.2 Europe Hybrid Composites Market, By Application (2022 and 2028)
9.3 Automotive
9.3.1 Overview
9.3.2 Automotive: Europe Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Aerospace
9.4.1 Overview
9.4.2 Aerospace: Europe Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Marine
9.5.1 Overview
9.5.2 Marine: Europe Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Wind Energy
9.6.1 Overview
9.6.2 Wind Energy: Europe Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Sporting Goods
9.7.1 Overview
9.7.2 Sporting Goods: Europe Hybrid Composites Market– Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Europe Hybrid Composites Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Hybrid Composites Market – Country Analysis
10.1 Overview
10.1.1 Europe Hybrid Composites Market, by Key Country–Revenue (2022) (US$ Million)
10.1.2 Europe Hybrid Composites Market, by Key Country
10.1.2.1 Germany: Europe Hybrid Composites Market–Revenue and Forecast to 2028 (US$ Million)
10.1.2.2 Germany: Europe Hybrid Composites Market–Volume and Forecast to 2028 (Kilo Tons)
10.1.2.2.1 Germany: Europe Hybrid Composites Market, by Fiber Type
10.1.2.2.2 Germany: Europe Hybrid Composites Market, by Fiber Type
10.1.2.2.3 Germany: Europe Hybrid Composites Market, by Resin
10.1.2.2.4 Germany: Europe Hybrid Composites Market, by Application
10.1.2.3 France: Europe Hybrid Composites Market–Revenue and Forecast to 2028 (US$ Million)
10.1.2.4 France: Europe Hybrid Composites Market–Volume and Forecast to 2028 (Kilo Tons)
10.1.2.4.1 France: Europe Hybrid Composites Market, by Fiber Type
10.1.2.4.2 France: Europe Hybrid Composites Market, by Fiber Type
10.1.2.4.3 France: Europe Hybrid Composites Market, by Resin
10.1.2.4.4 France: Europe Hybrid Composites Market, by Application
10.1.2.5 Italy: Europe Hybrid Composites Market–Revenue and Forecast to 2028 (US$ Million)
10.1.2.6 Italy: Europe Hybrid Composites Market–Volume and Forecast to 2028 (Kilo Tons)
10.1.2.6.1 Italy: Europe Hybrid Composites Market, by Fiber Type
10.1.2.6.2 Italy: Europe Hybrid Composites Market, by Fiber Type
10.1.2.6.3 Italy: Europe Hybrid Composites Market, by Resin
10.1.2.6.4 Italy: Europe Hybrid Composites Market, by Application
10.1.2.7 United Kingdom: Europe Hybrid Composites Market–Revenue and Forecast to 2028 (US$ Million)
10.1.2.8 United Kingdom: Europe Hybrid Composites Market–Volume and Forecast to 2028 (Kilo Tons)
10.1.2.8.1 United Kingdom: Europe Hybrid Composites Market, by Fiber Type
10.1.2.8.2 United Kingdom: Europe Hybrid Composites Market, by Fiber Type
10.1.2.8.3 United Kingdom: Europe Hybrid Composites Market, by Resin
10.1.2.8.4 United Kingdom: Europe Hybrid Composites Market, by Application
10.1.2.9 Russia: Europe Hybrid Composites Market–Revenue and Forecast to 2028 (US$ Million)
10.1.2.10 Russia: Europe Hybrid Composites Market–Volume and Forecast to 2028 (Kilo Tons)
10.1.2.10.1 Russia: Europe Hybrid Composites Market, by Fiber Type
10.1.2.10.2 Russia: Europe Hybrid Composites Market, by Fiber Type
10.1.2.10.3 Russia: Europe Hybrid Composites Market, by Resin
10.1.2.10.4 Russia: Europe Hybrid Composites Market, by Application
10.1.2.11 Rest of Europe: Europe Hybrid Composites Market –Revenue and Forecast to 2028 (US$ Million)
10.1.2.12 Rest of Europe: Europe Hybrid Composites Market – Volume and Forecast to 2028 (Kilo Tons)
10.1.2.12.1 Rest of Europe: Europe Hybrid Composites Market, by Fiber Type
10.1.2.12.2 Rest of Europe: Europe Hybrid Composites Market, by Fiber Type
10.1.2.12.3 Rest of Europe: Europe Hybrid Composites Market, by Resin
10.1.2.12.4 Rest of Europe: Europe Hybrid Composites Market, by Application
11. Europe Hybrid Composite Market Industry Landscape
11.1 Overview
11.2 Product Launch
11.3 Merger and Acquisitions
11.4 Partnerships
11.5 Expansion
12. Company Profiles
12.1 Hexcel Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Lanxess AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 SGL Carbon SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Gurit Holding AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Avient Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Teijin Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Solvay SA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Toray Industries Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Mitsubishi Chemical Holdings Corp
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms

LIST OF TABLES

Table 1. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Segmentation
Table 2. Instruments: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Table 3. Consumables: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Table 4. Recent Inorganic Growth Strategies in the Fluorescence In-situ Hybridization (FISH) Imaging Systems Market
Table 5. Recent Organic Growth Strategies in the Fluorescence In-situ Hybridization (FISH) Imaging Systems Market
Table 6. Glossary of Terms, Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market

LIST OF FIGURES

Figure 1. US PEST Analysis
Figure 2. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2020 – 2030
Figure 5. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Instruments: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Consumables: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Accessories: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Software: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
Figure 11. Cancer Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disease Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infectious Disease Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
Figure 16. Diagnostic Laboratories: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Contract Research Organization: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Pharmaceutical And Biotechnological Companies: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Growth Strategies in the Fluorescence In-situ Hybridization (FISH) Imaging Systems Market

The List of Companies – U.S. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
– Euroclone SpA
– TissueGnostics GmbH
– Agilent Technologies Inc
– Abnova Taiwan Corp
– BioGenex Laboratories Inc
– Leica Biosystems Nussloch GmbH
– MetaSystems Probes GmbH
– Bio-View Ltd
– Thermo Fisher Scientific Inc
– Applied Spectral Imaging
– PerkinElmer Inc

Reviews

There are no reviews yet.

Be the first to review “US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Size and Forecasts (2020 – 2030)”